Tag: Renato Dellamano

Market access trends across the EU5: 2009 to 2016—an update.

December 1, 2017
Read More

ISPOR Pricing Short Course with Jack Mycka and Renato Dellamano at 20th Annual European Congress

October 20, 2017
Read More

Market access of cellular and gene therapy products in the US and EU5.

June 1, 2017
Read More

ISPOR Pricing Short Courses with Jack Mycka and Renato Dellamano at 22nd Annual International Meeting

March 14, 2017
Read More

Advanced therapy medicinal products (ATMPs) in Europe 8 years on: what is the path to market access so far?

November 1, 2016
Read More

ISPOR Pricing Short Course with Jack Mycka and Renato Dellamano at 19th Annual European Congress

July 27, 2016
Read More

Market access trends across the EU5: 2010 to 2015.

June 1, 2016
Read More

Regulatory approval to patient access: an evaluation of EU5 and US national timing differences—an update (2009-2015).

June 1, 2016
Read More

ISPOR Pricing Short Courses with Jack Mycka and Renato Dellamano at 21st Annual International Meeting

January 27, 2016
Read More

Orphan drug assessments in Germany in comparison with other international HTA agencies.

December 1, 2015
Read More
Categories

let's talk!